Tenet Healthcare (NYSE: THC) officer awarded 9,448 performance-based shares

Rhea-AI Filing Summary

Tenet Healthcare’s principal accounting officer, Ramsey R. Scott, received an equity award. On the reported date, he acquired 9,448 shares of Tenet Healthcare common stock as a grant of performance-based restricted stock at a price of $0 per share.

Following this grant, his directly held common stock totaled 9,448 shares. The award was earned when the company’s Human Resources Committee certified that performance targets were achieved for the performance period from January 1, 2023 to December 31, 2025, based on the extent to which the applicable performance goals were attained.

Insider Trade Summary

Net Buyer: 9,448 shares

Net Buy 1 txn

Insider Ramsey R. Scott

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,448	$0.00	$0.00

Holdings After Transaction: Common Stock — 9,448 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2023 to December 31, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/17/2026 - 08:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Tenet Healthcare (THC) report for Ramsey R. Scott?

Tenet Healthcare reported that principal accounting officer Ramsey R. Scott acquired 9,448 shares of common stock through a performance-based restricted stock grant. The shares were granted at $0 per share after performance targets were certified by the company’s Human Resources Committee.

How many Tenet Healthcare (THC) shares does Ramsey R. Scott hold after this Form 4?

After the reported grant, Ramsey R. Scott directly holds 9,448 shares of Tenet Healthcare common stock. This total reflects the full amount of the performance-based restricted stock award that was earned upon certification of the applicable performance goals for the stated period.

What type of equity award did Tenet Healthcare (THC) grant to Ramsey R. Scott?

Ramsey R. Scott received a grant of performance-based restricted stock totaling 9,448 shares of Tenet Healthcare common stock. The award was earned when the Human Resources Committee certified achievement of performance targets for the performance period from January 1, 2023 to December 31, 2025.

At what price per share was the Tenet Healthcare (THC) award to Ramsey R. Scott recorded?

The 9,448-share performance-based restricted stock grant to Ramsey R. Scott was recorded at a transaction price of $0 per share. This reflects the nature of the grant as an equity award rather than an open-market purchase of Tenet Healthcare common stock.

What performance period is tied to Ramsey R. Scott’s Tenet Healthcare (THC) stock grant?

The performance-based restricted stock grant to Ramsey R. Scott is tied to a performance period from January 1, 2023 to December 31, 2025. The shares were earned once the Human Resources Committee certified that the applicable performance goals for this period had been achieved.

Who approved the performance-based stock grant reported for Tenet Healthcare (THC)?

The grant was earned on the date Tenet Healthcare’s Human Resources Committee certified achievement of the applicable performance targets. Their certification, based on the extent the performance goals were attained for the January 1, 2023 to December 31, 2025 period, triggered the award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ramsey R. Scott

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		A(1)		9,448	A	$0	9,448	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2023 to December 31, 2025.

	Chad J. Wiener, as Attorney-in-fact for R. Scott Ramsey	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.